Published in Dokl Biochem Biophys on August 06, 2008
Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS One (2012) 0.91
Highly sensitive nuclease assays based on chemically modified DNA or RNA. Sensors (Basel) (2014) 0.80
MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy. PLoS One (2013) 0.75
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
MicroRNAs and the hallmarks of cancer. Oncogene (2006) 2.55
Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood (1999) 2.49
Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res (2002) 2.21
Ribonuclease A variants with potent cytotoxic activity. Proc Natl Acad Sci U S A (1998) 1.64
Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway. J Cell Sci (2003) 1.18
Conformational stability is a determinant of ribonuclease A cytotoxicity. J Biol Chem (2000) 1.16
Mechanism of ribonuclease cytotoxicity. J Biol Chem (1995) 1.13
Effect of deoxyribonuclease on the course of lymphatic leukaemia in AKR mice. Nature (1967) 1.07
Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. Blood (2001) 1.04
Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor. FEBS Lett (2005) 0.89
Deoxyribonuclease treatment prevents blood-borne liver metastasis of cutaneously transplanted tumour cells in mice. Br J Cancer (1993) 0.79
Antitumor action of bovine seminal ribonuclease. Neoplasma (1996) 0.79
Antitumor activity and other biological actions of oligomers of ribonuclease A. J Biol Chem (2003) 0.77
Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of bovine pancreatic ribonuclease (RNase A) inhibit growth of human melanoma in nude mice. J Drug Target (2002) 0.76
[The loss of the subject of science]. Voen Med Zh (1994) 1.45
Isolation of ribosomal subunits containing intact rRNA from human placenta: estimation of functional activity of 80S ribosomes. Anal Biochem (1991) 1.18
Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch Virol (1995) 1.14
Sebaceous glands of the woolly mammoth, Mammothus primigenius Blum: histological evidence. Dokl Biol Sci (2004) 1.10
RNase T1 mimicking artificial ribonuclease. Nucleic Acids Res (2007) 0.95
Studying functional significance of the sequence 980-1061 in the central domain of human 18S rRNA using complementary DNA probes. Biochim Biophys Acta (1997) 0.94
[Automated H-phosphonate synthesis of oligoribonucleotides using 2'-O-tetrahydropyranyl protective group]. Bioorg Khim (1990) 0.93
Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence. Virus Res (1994) 0.92
Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice. Biomed Sci (1991) 0.90
Arrangement of mRNA at the decoding site of human ribosomes. 18S rRNA nucleotides and ribosomal proteins cross-linked to oligouridylate derivatives with alkylating groups at either the 3' or the 5' termini. Eur J Biochem (1994) 0.89
[RNA hydrolysis catalyzed by imidazole as a reaction for studying the secondary structure of RNA and complexes of RNA with oligonucleotides]. Dokl Akad Nauk (1996) 0.87
[In vitro suppression of translation of tick-borne encephalitis virus RNA using antisense nucleotides]. Mol Biol (Mosk) (1993) 0.87
Hybridization of antisense oligonucleotides with the 3'part of tRNA(Phe). FEBS Lett (1999) 0.85
Secondary structure of the 5'-region of PGY1/MDR1 mRNA. FEBS Lett (2000) 0.85
Cleavage of RNA with synthetic ribonuclease mimics. Methods Enzymol (2000) 0.85
Nucleic acids in exosomes: disease markers and intercellular communication molecules. Biochemistry (Mosc) (2013) 0.84
[Derivatives of oligonucleotides complementary to viral RNA inhibit replication of tick-borne encephalitis virus in a cell culture]. Dokl Akad Nauk SSSR (1988) 0.84
[Circulating nucleic acids in blood of patients with stomach and colon neoplasms]. Biomed Khim (2005) 0.84
Cleavage of RNA by an amphiphilic compound lacking traditional catalytic groups. Bioorg Chem (2007) 0.84
[Sensitized photomodification by binary systems. I. Synthesis of oligonucleotide reagents, and the effect of their structure on the efficacy of target modification]. Bioorg Khim (1997) 0.84
Immunoproteasome enhances intracellular proteolysis of myelin basic protein. Dokl Biochem Biophys (2014) 0.84
[Transport of oligonucleotides-cell surface proteins complexes into cell nucleus]. Dokl Akad Nauk (1999) 0.84
Structural arrangement of the decoding site of Escherichia coli ribosomes as revealed from the data on affinity labelling of ribosomes by analogs of mRNA--derivatives of oligoribonucleotides. Biochim Biophys Acta (1990) 0.83
[Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference]. Mol Biol (Mosk) (2010) 0.83
Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09). Bull Exp Biol Med (2010) 0.83
Cleavage of yeast tRNAPhe with complementary oligonucleotide conjugated to a small ribonuclease mimic. FEBS Lett (2000) 0.83
[Suppression of immunoglobulin synthesis in myeloma MORS 21 cells by an alkylating oligonucleotide derivative complementary to the mRNA coding for light-chain immunoglobulin]. Dokl Akad Nauk SSSR (1984) 0.83
[Emerging problems of medical ethics in Russia: medical practice and research]. Kardiologiia (2002) 0.82
Identification of a site on 18 S rRNA of human placenta ribosomes in the region of the mRNA binding center. J Mol Biol (1990) 0.81
[Circulating deoxyribonucleic acids in blood and their using in medical diagnostics]. Mol Biol (Mosk) (2008) 0.81
[Cholesteroyl derivatives of oligoethylenimine as mediators of transfection of eukaryotic cells in gene therapy]. Dokl Akad Nauk (1998) 0.81
Experimental approach to study of the gonadotropin-releasing hormone function by knockdown of its expression with RNA interference in ontogenesis. Dokl Biol Sci (2009) 0.80
[Synthetic ribonucleases. 1. Synthesis and properties of conjugates, containing an RNA-binding fragment based on lysine residues and an RNA hydrolyzing fragment, bearing an imidazole residue]. Bioorg Khim (1999) 0.80
Artificial ribonucleases: oligonucleotide-peptide conjugates that cleave RNA at the GpX and PypA phosphodiester bonds. Dokl Biochem Biophys (2002) 0.80
[Mechanism of oligonucleotide hybridization with the 3'-terminal region of yeast tRNA(Phe)]. Mol Biol (Mosk) (2000) 0.79
[Affinity modification of 80S ribosomes from human placenta by derivatives of tri- and hexauridylates as mRNA analogs]. Mol Biol (Mosk) (1993) 0.79
Functional topography of human ribosomes as studied by affinity labeling with reactive mRNA analogs. Biochimie (1992) 0.79
Plasma content of extracellular nucleic acids in donors and patients with mammary tumors. Bull Exp Biol Med (2005) 0.79
Ribonuclease activity of the peptides with alternating arginine and leucine residues conjugated to tetrathymidilate. Nucleosides Nucleotides Nucleic Acids (2004) 0.78
Viral genome cleavage with artificial ribonucleases: a new method to inactivate RNA-containing viruses. Dokl Biochem Biophys (2009) 0.78
[Mechanism for suppression mRNA translation with antisense oligonucleotides]. Mol Biol (Mosk) (1991) 0.78
Antiproliferative and interferon-inducing activities of unique short double-stranded RNA. Dokl Biochem Biophys (2011) 0.78
A Comparison of Target Gene Silencing using Synthetically Modified siRNA and shRNA That Express Recombinant Lentiviral Vectors. Acta Naturae (2009) 0.78
[Breast cancer diagnostics based on extracellular DNA and RNA circulating in blood]. Biomed Khim (2008) 0.78
[Intramolecular addressed alkylation of 2',3'-0-(4-(chloroethyl-methylamino)benzylidene)-tRNA]. Mol Biol (1976) 0.78
[Stabilization of DNA-duplexes by minor groove binding ligands with formation of a complex type 1:2 with parallel orientation of ligands in the minor groove]. Dokl Akad Nauk (1999) 0.77
[An RNA sequence determines the speed of its splitting by artificial ribonucleases]. Bioorg Khim (2010) 0.77
[Site-specific cleavage of yeast tRNA(Phe) by derivatives of oligonucleotides bearing bisimidazole groups]. Dokl Akad Nauk (1999) 0.77
[Characterization of the H5N1 influenza virus isolated during an outbreak among wild birds in Russia (Tuva Republic) in 2010]. Mol Gen Mikrobiol Virusol (2011) 0.77
[Directed chemical modification of DNA fragments by perfluorarylazide derivatives of oligonucleotides in the presence of oligonucleotides bearing photosensitized pyrene groups]. Dokl Akad Nauk (1995) 0.77
[Extraembryonic endoderm stem cell lines from common voles of the genus Microtus]. Genetika (2008) 0.77
[Secondary structure of 5'-terminal region of mRNA of human multidrug resistance gene]. Mol Biol (Mosk) (2000) 0.77
Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs. Dokl Biol Sci (2004) 0.77
[Highly efficient site-directed RNA cleavage by imidazole-containing conjugates of antisense oligonucleotides]. Mol Biol (Mosk) (2002) 0.77
A pseudovirus system for the testing of antiviral activity of compounds in different cell lines. Dokl Biochem Biophys (2010) 0.77
Proteins involved in binding and cellular uptake of nucleic acids. Biochemistry (Mosc) (2006) 0.76
A glycolipid containing a lactose residue: a novel agent for targeted DNA delivery for the purpose of genetic therapy. Dokl Biochem Biophys (2005) 0.76
[Assay of methylated gene RARbeta2 in circulating DNA of blood from patients with lung cancer as a potential prognostic marker]. Vopr Onkol (2011) 0.76
[Kinetic parameters of hydrolysis of CpA and UpA sequences in an oligoribonucleotide by compounds functionally mimicking ribonuclease A]. Mol Biol (Mosk) (2002) 0.76
Antitumor effect of the LIVP-GFP recombinant vaccinia virus. Dokl Biol Sci (2013) 0.76
[Molecular-genetic markers in lung cancer diagnostics]. Mol Biol (Mosk) (2011) 0.76
[Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency]. Mol Biol (Mosk) (2015) 0.76
Synthesis of nanoscale TiO2 and study of the effect of their crystal structure on single cell response. ScientificWorldJournal (2012) 0.76
[Unfolding of the tRNA(Phe) structure by complementary oligonucleotides]. Dokl Akad Nauk (1998) 0.76
[Chemical ribonucleases. 3. Synthesis of organic catalysts of hydrolysis of phosphodiester bonds based on quaternary salts of 1,4-diazabicyclo(2.2.2)octane]. Bioorg Khim (2000) 0.76
Use of primary human fetal chondroblast culture for xenotransplantation into rat articular cartilage defect. Bull Exp Biol Med (2008) 0.76
[Cholesterol-modified anti-MDR1 small interfering RNA: uptake and biological activity]. Mol Biol (Mosk) (2010) 0.76
Tumoricidal Activity of RNase A and DNase I. Acta Naturae (2010) 0.76
Silencing of Her2, CCNB1 and PKC Genes by siRNA Results in Prolonged Retardation of Neuroblastoma Cell Division. Acta Naturae (2011) 0.75
[Antisense oligonucleotides inhibiting ribosomal functions in mycobacteria]. Izv Akad Nauk Ser Biol (2005) 0.75
Comparative analysis of HBV M-antigen production in leaves of individual transgenic carrot plants. Dokl Biochem Biophys (2009) 0.75
[Investigation of the impact of cowpox virus BTB/kelch gene deletion on some characteristics of infection in vitro]. Vopr Virusol (2009) 0.75
[Immunochemical and molecular-genetic markers in gastric cancer diagnostics]. Biomed Khim (2009) 0.75
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. Acta Naturae (2009) 0.75
Short double-stranded RNA suppresses multiple drug resistance gene expression in tumor cells. Dokl Biochem Biophys (2002) 0.75
[Complementary DNA modification in metaphase chromosomes and interphase chromatin]. Dokl Akad Nauk SSSR (1987) 0.75
[A complication of catheterization of the subclavian vein]. Klin Khir (1987) 0.75